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A novel series of 1-(2-chlorobenzyloxy)-3-[1,2,3]triazol-1-yl-propan-2-ol derivatives was designed and synthesized using copper
catalyzed alkyne-azide cycloaddition in the key step. Theoretical investigation of molecular and electronic properties by means
of global and local reactivity indexes of the synthetized compounds was carried out, using DFT (Density Functional Theory) at
PBEPBE/6-31++G∗∗ level.
1. Introduction
Depression and similar psychological disorders affect about
350 million people worldwide and represent one of the
leading causes of disability and a major contributor to the
burden of suicide and ischemic heart diseases [1, 2]. This
illness is associated with a decreased production of serotonin
in conjunction with a decreased sensitivity of postsynaptic
receptors to available serotonin [3].Therefore, one of themost
extended current therapies for this kind of diseases involve
the use of commercially available drugs which work as selec-
tive serotonin reuptake inhibitors (SSRI) such as fluoxetine
among other analogous compounds [4, 5]. Although all these
compounds are effective as antidepressants, some side effects
are observed during their use. This reason has motivated the
design and development of diverse molecules, which display
good reuptake inhibiting activity [6–8].
A particular molecule that has attracted us is a deriva-
tive from chlorobenzyloxy-3,6-dihydropyridinyl propan-2-
ol named DJLDU-3-79, 1 [9]. This compound was designed
from a hybridization of two active reuptake inhibitory
molecules in order to improve the above-mentioned prop-
erties. However, a synthetic challenge in the preparation of
thismolecule is the tetrahydropyridinemoiety prepared from
4-piperidone analogs, which in turn are obtained through
several reaction steps [10, 11]. In this regard, we propose
a synthesis of a novel family of compounds 2 analogs to
molecule 1 based on a substitution of tetrahydropyridine
ring by 1,2,3-triazole which is easily synthesized by copper
catalyzed alkyne-azide cycloaddition (CuAAC), the most
powerful click reaction (Scheme 1).
On the other hand, DFT-based methods have already
proven to be useful in determining molecular structure of
organic compounds, as well as in elucidating their electronic
structure and reactivity [12]. There are two kinds of DFT-
based reactivity indexes: global and local quantities. The
global parameters measure the electronic features of the
molecules as a whole and the local quantity reflects the
reactivity of particular regions or atoms. The properties
calculated in this study have been successfully applied in to
explain the reactivity of organic and inorganic molecules,
proteins, solids, and others [13].
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Scheme 1: Structure of DJLDU-3-79 (1) and general structure for
molecules 2 proposed in this work.
Several studies have confirmed closed relationships
between the biological performance of a family of com-
pounds and their chemical reactivity. The pharmacokinetic
and pharmacodynamic properties of SSRI molecules are
strongly influenced by their interactions to the body proteins
[9]. Therefore, the electron transfer properties in protein-
ligand binding could be studied by using DFT reactivity
indexes. To accomplish this goal, the use of global chemical
reactivity parameters, chemical potential (𝐼), electron affinity
(𝐴), chemical potential (𝜇), softness (𝑆), and electrophilicity
(𝜔), could aid the understanding of the interaction process
between SSRI and biological molecules. Also, the local
parameters could give some light about which molecular
moieties are most involved in the binding structure
This report summarizes our most recent findings in
the click chemistry area aiming to search and develop
new molecules with high SSRI activity; also the theoreti-
cal characterization of the obtained molecules was carried
out.
2. Experimental Section
2.1. Synthesis. The starting materials were purchased from
Aldrich Chemical Co. and were used without further purifi-
cation. Solvents were distilled before use. Silica plates of
0.20 mm thickness were used for thin layer chromatography.
Melting points were determined with a Kru¨ss Optronic
melting point apparatus and they are uncorrected. 1H and
13C NMR spectra were recorded using a Bruker AVANCE
300; the chemical shifts (𝛿) are given in ppm relative to TMS
as internal standard (0.00). For analytical purposes the mass
spectra were recorded on a Shimadzu GCMS-QP2010 Plus
in the EI mode, 70 eV, 200∘C via direct inlet probe. Only the
molecular and parent ions (m/z) are reported. IR spectra were
recorded on a Bruker TENSOR 27 FT instrument.
2.1.1. 2-Chlorophenyl-methanol (4). A solution of 2-chlorob-
enzaldehyde (1.125mL, 1.40 g, 10.03mmol) in ethanol (15mL)
was added to a suspension of sodium borohydride (0.189 g,
4.97mmol) in absolute ethanol (6mL) maintaining the
temperature below 25∘C. The resulting mixture was heated
at 50∘C during 1.5 h. The solvent was removed in vacuo, and
water (20mL) was added; the mixture was acidified with
diluted HCl (10%) to pH = 5.The product was extracted with
CH2Cl2 (3× 15mL), the organic phases were joined and dried
over Na2SO4, and the solvent was removed in vacuo to yield a
white solid (1.27 g, 90%), which was used without additional
purification, m.p. 50∘C; 1H NMR (300MHz, CDCl3) 𝛿 7.49
(dd, J = 7.3, 2.0Hz, 1H), 7.37 (dd, J = 7.5, 1.8Hz, 1H), 7.32–7.20
(m, 2H), 4.79 (d, J = 6.0Hz, 1H), 1.69 (s, 1H); 13C NMR
(75MHz, CDCl3) 𝛿 137.1, 131.6, 128.2, 127.7, 127.6, 125.9, 61.7;
IR (ATR, cm−1): 3302, 3216, 2912, 2859, 1439; MS [EI+] m/z
(%): 142 [M]+ (1), 107 [C7H7O]
+ (35), 77 [C6H5]
+ (100), 51
[C4H3]
+ (91).
2.1.2. 2-(2-Chloro-benzyloxymethyl)-oxirane (5). A mixture
of 40% aqueous solution of NaOH (6.5mL) (2-chloro-
phenyl)-methanol 4 (0.71 g, 5mmol) and tetrabutylammo-
nium iodide (0.09 g, 0.25mmol) was vigorously stirred at
room temperature for 24 h. The mixture was cooled to 0∘C
and epichlorohydrin (1.55mL, 1.83 g, and 19.9mmol) was
added dropwise. After completion, the reaction mixture was
stirred at 0∘C for 30 minutes and at room temperature
overnight. The mixture was poured into ice cold water
(20mL).The product was extracted with CH2Cl2 (3 × 15mL),
the organic phases were joined and dried over Na2SO4, and
the solvent was removed in vacuo to yield a pale yellow oil
(1.27 g, 90%), whichwas usedwithout additional purification;
1H NMR (300MHz, CDCl3) 𝛿 7.50 (dd, J = 7.4, 2.1 Hz, 1H),
7.35 (dd, J = 7.4, 1.8Hz, 1H), 7.31–7.19 (m, 2H), 4.68 (d, J =
3.9Hz, 2H), 3.49–3.87 (dd, J = 11.4, 5.8Hz, 2H), 3.27–3.18 (m,
1H), 2.65–2.82 (dd, J = 5.0, 2.7Hz, 2H); 13C NMR (75MHz,
CDCl3) 𝛿 135.4, 132.6, 129.0, 128.7, 128.5, 126.5, 71.1, 69.9, 50.5,
43.9; IR (ATR, cm−1): 3061, 2998, 2923, 2864, 1250, 1096; MS
[EI+]m/z (%): 198 [M]+ (5), 56 [C3H5O]+ (100). HRMS (EI):
calcd. For C10H11ClO2: 198.0448; found: 198.0442.
2.1.3. 1-Azido-3-(2-chloro-benzyloxy)-propan-2-ol (6). 2-(2-
Chloro-benzyloxymethyl)-oxirane 5 (0.965 g, 4.86mmol),
NH4Cl (0.529 g, 9.89mmol), and NaN3 (2.652 g, 40.8mmol)
were added successively to a mixture of MeOH (8mL) and
H2O (1mL) and the reaction mixture was stirred at room
temperature for 24 h. The solvent was removed in vacuo
and the product was extracted with AcOEt (3 × 15mL);
the organic phases were joined and dried over Na2SO4 and
the solvent was removed in vacuo to yield a pale yellow
oil (1.2981 g, 74.12%), which was used without additional
purification; 1H NMR (300MHz, CDCl3) 𝛿 7.40 (dd, J
= 7.2, 2.2Hz, 1H), 7.35–7.30 (m, 1H), 7.29–7.16 (m, 2H),
4.60 (s, 2H), 3.94 (ddd, J = 10.8, 5.9, 4.9Hz, 2H), 3.54
(s, broad, 1H), 3.52–3.34 (ddd, J = 5.4, 2.3, 1.3Hz, 2H),
3.22 (s, 1H); 13C NMR (75MHz, CDCl3) 𝛿 135.3, 133.2,
129.4, 129.4, 129.1, 126.9, 71.85, 70.6, 69.6, 53.5; IR (ATR,
cm−1): 3426, 2097, 1092, 751; MS [EI+] m/z (%): 241 [M]+
(5), 149 [M-C7H6ClO]
+ (100), 125 [M-C7H6Cl]
+ (90), 107
[M- C3H6N3O]+ (90), 89 [M-C2H4N3O]
+ (60), 43 [M-N3]
+
(65). HRMS (EI): calcd. For C10H12ClN3O2: 241.0618; found:
241.0622.
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2.2. General Procedure for the Synthesis of 1-(2-Chloro-
benzyloxy)-3-[1,2,3]triazol-1-yl-propan-2-oles. The appropri-
ate alkyne (1mol) was added in one portion to a solution
of 1-azido-3-(2-chloro-benzyloxy)-propan-2-ol 6 (0.241 g,
1mmol), CuI (0.009 g, 0.05mmol), and DIPEA (0.17mL,
0.129 g, 1mmol) in CH2Cl2 (15mL). The resulting mixture
was stirred at room temperature for 24 h. An aqueous
solution of 2% EDTA (30mL) was added and the stirring was
continued for additional 24 h.Theproduct was extractedwith
CH2Cl2 (3× 15mL), the organic phases were joined and dried
over Na2SO4, the solvent was removed in vacuo, and the final
product was purified by crystallization.
2.2.1. 1-(2-Chlorobenzyloxy)-3-(4-phenyl-[1,2,3]triazol-1-yl)-
propan-2-ol (7). White solid; yield: 85%; mp 58∘C; 1H NMR
(300MHz, CDCl3) 𝛿 7.86 (s, 1H), 7.78–7.65 (m, 2H), 7.47–7.30
(m, 5H), 7.32 (s, 1H), 7.30–7.20 (m, 2H), 4.65 (s, 2H), 4.64–4.57
(m), 4.49 (dd, J = 8.7, 7.0Hz, 1H), 4.48–4.36 (m, 1H), 3.59–3.52
(m, 1H), 3.44–3.37 (m, 1H), 2.62 (s, broad, 1H); 13C NMR
(75MHz, CDCl3) 𝛿 135.3, 133.2, 129.4, 129.4, 129.1, 126.9, 71.8,
70.6, 69.6, 53.5; IR (ATR, cm−1): 3227, 3061, 2866, 1440, 750;
MS [EI+]m/z (%): 343 [M]+ (5), 125 [C7H6Cl]+ (100). HRMS
(EI): calcd. For C18H18ClN3O2: 343.1088; found: 343.1091.
2.2.2. 1-(2-Chlorobenzyloxy)-3-(4-p-tolyloxymethyl-[1,2,3]tri-
azol-1-yl)-propan-2-ol (8). White solid; yield: 99%; mp 25∘C;
1H NMR (300MHz, CDCl3) 𝛿 7.70 (s, 1H), 7.46 (dd, J = 7.6,
1.7Hz, 1H), 7.41 (dd, J = 3.8, 1.7Hz, 1H), 7.27 (dd, J = 12.2,
1.8Hz, 1H), 7.20–7.13 (m, 1H), 7.05 (d, J = 8.5Hz, 2H), 6.87 (d,
J = 2.3Hz, 1H), 6.83 (d, J = 2.1Hz, 1H), 5.08 (s, 2H), 4.57 (s,
2H), 4.52–4.36 (dddd, J = 13.9, 14.0, 3.8, 7.1 Hz, 2H), 4.20 (dd,
J = 9.2, 5.2Hz, 1H), 3.53–3.46 (ddd, J = 9.7, 5.4, 4.9Hz, 2H),
2.49 (s, broad, 1H), 2.25 (s, 3H); 13C NMR (75MHz, CDCl3)
𝛿 155.1, 143.0, 134.7, 134.2, 132.3, 129.5, 128.5, 128.5, 127.9, 125.8,
123.4, 113.8, 70.6, 69.5, 68.1, 60.93, 52.1, 19.5; IR (ATR, cm−1):
3312, 2925, 2860, 1269, 1120; MS [EI+]m/z (%): 387 [M]+ (5),
125 [C7H6Cl]
+ (100). HRMS (EI): calcd. For C20H22ClN3O3:
387.1350; found: 387.1351.
2.2.3. 1-(2-Chlorobenzyloxy)-3-[4-(4-methoxy-phenoxymeth-
yl)-[1,2,3]triazol-1-yl]-propan-2-ol (9). White solid; yield:
46%; mp 76∘C; 1H NMR (300MHz, CDCl3) 𝛿 7.78 (s, 1H),
7.75–7.68 (m, 2H), 7.39 (dd, J = 10.7, 4.2Hz, 2H), 7.31–7.20 (m,
2H), 6.95 (d, J = 8.4Hz, 2H), 4.65 (s, 1H), 4.60–4.46 (dddd, J
= 14.2, 3.6, 14.0, 6.8Hz, 2H), 4.36–4.26 (m, 1H), 3.84 (s, 3H),
3.63–3.53 (ddd J = 9.8, 4.9, 9.7, 5.7Hz, 2H), 2.04 (s, broad, 1H);
13C NMR (75MHz, CDCl3) 𝛿 159.6, 147.5, 135.0, 133.5 de C3,
129.6, 129.6, 129.3, 126.9, 126.9, 126.9, 120.4, 114.2, 71.3, 70.8,
69.3, 55.3, 52.9; IR (ATR, cm−1): 3256, 3141, 2958, 2924, 2854,
1360, 1249; MS [EI+] m/z (%): 403 [M]+ (28), 125 [C7H6Cl]+
(100).
2.2.4. 1-(2-Chlorobenzyloxy)-3-(4-p-tolyl-[1,2,3]triazol-1-yl)-
propan-2-ol (10). White solid; yield: 51%; mp 120∘C; 1H
NMR (300MHz, CDCl3) 𝛿 7.81 (s, 1H), 7.64–7.55 (m, 2H),
7.42 (dd, J = 6.4, 2.9Hz, 1H), 7.29–7.14 (m, 5H), 4.64 (s, 2H),
4.58–4.45 (dddd, J = 14.0, 7.2, 3.8, 4.8Hz, 2H), 4.44–4.38 (m,
1H), 3.61–3.57 (m, 2H), 2.36 (s, 3H), 1.26 (s, broad, 1H); 13C
NMR (75MHz, CDCl3) 𝛿 155.1, 143.0, 134.7, 134.22, 132.3,
129.5, 128.5, 128.8, 127.9, 125.8, 123.4, 113.8, 70.6, 69.5, 68.1,
60.9, 52.1, 19.5; IR (ATR, cm−1): 3392, 2918, 2865, 1442, 1107;
MS [EI+]m/z (%): 357 [M]+ (5), 125 [C7H6Cl]+ (100). HRMS
(EI): calcd. For C19H20ClN3O2: 357.1244; found: 357.1247.
2.2.5. 2-{1-[3-(2-Chlorobenzyloxy)-2-hydroxy-propyl]-1H-[1,2,
3]triazol-4-ylmethyl}-2-methyl-cyclopentane-1,3-dione (11).
Colorless oil; yield: 66%; 1H NMR (300MHz, CDCl3) 𝛿 7.44
(s, 1H), 7.48–7.41 (m, 1H), 7.36–7.31 (m, 1H), 7.26–7.19 (m, 2H),
4.60 (s, 2H), 4.46–4.29 (dddd, J = 14.0, 13.9, 7.3, 3.6Hz, 2H),
4.14 (dq, J = 9.4, 5.3Hz, 1H), 3.50 (d, J = 5.2Hz, 2H), 3.05 (s,
2H), 2.80 (d, J = 3.2Hz, 4H), 2.01 (s, broad, 1H), 1.17 (s, 3H);
13C NMR (75MHz, CDCl3) 𝛿 212.2, 202.7, 137.5, 130.5, 128.0,
124.5, 124.4, 124.1, 122.02, 118.20, 66.9, 65.6, 64.1, 50.3, 48.1,
30.1, 26.0, 25.9, 25.3; IR (ATR, cm−1): 3304, 2925, 2869, 1442,
1361, 1219; MS [EI+] m/z (%): 391 [M]+ (10), 125 [C7H6Cl]+
(100). HRMS (EI): calcd. For C19H22ClN3O4: 391.1299; found:
391.1303.
2.2.6. 3-{1-[3-(2-Chlorobenzyloxy)-2-hydroxy-propyl]-[1,2,3]
triazol-4-yl}-propan-1-ol (12). Colorless oil; yield: 84%; 1H
NMR (300MHz, CDCl3) 𝛿 7.44 (s, 1H), 7.43–7.35 (m, 1H),
7.30–7.21 (m, 3H), 4.78 (s, broad, 1H), 4.64 (s, 2H), 4.53–4.38
(dddd, J = 14.0, 14.0, 7.1, 3.6Hz), 4.28–4.20 (m, 1H), 3.66 (t, J =
6.4Hz, 2H), 3.58–3.51 (dddd, J = 9.7, 9.7, 5.5, 5.0Hz, 2H), 2.79
(t, J = 7.4Hz, 2H), 2.17 (s, broad, 1H), 1.89 (p, J = 6.6Hz, 2H);
13C NMR (75MHz, CDCl3) 𝛿 147.0, 134.8, 133.1, 129.3, 129.2,
126.6, 122.3, 71.2, 70.5, 68.8, 61.3, 52.6, 31.5, 21.7; IR (ATR,
cm−1): 3487, 2912, 2862, 1716, 1446, 1219; MS [EI+] m/z (%):
325 [M]+ (10), 126 [C5H8N3O]
+ (100). HRMS (EI): calcd. For
C15H20ClN3O3: 325.1193; found: 325.1195.
2.2.7. 1-(2-Chlorobenzyloxy)-3-[4-(4-nitro-phenoxymethyl)-[1,
2,3]triazol-1-yl]-propan-2-ol (13). White solid; yield: 55%;mp
85∘C; 1HNMR (300MHz, CDCl3) 𝛿 8.20 (d, J = 8.2Hz, 2H),
8.17 (d, 𝐽 = 2.1Hz, 2H), 7.81 (s, 1H), 7.43–7.23 (m, 4H), 7.08
(m, 2H), 4.63 (d, J = 1.1 Hz, 2H), 4.62 (dddd, 𝐽 = 14.1,
14.0 7.1, 4.6Hz, 2H), 4.30 (m, 1H), 3.64–3.49 (dddd, 𝐽 =
9.7, 9.7, 5.0, 4.7Hz, 2H), 2.16 (s, 1H); 13C NMR (75MHz,
CDCl3) 𝛿 162.7, 142.1, 141.4, 134.6, 132.9, 129.2, 129.2, 128.9,
126.5, 125.5, 124.4, 114.5, 71.0, 70.4, 68.75, 52.7; IR (ATR, cm−1):
3253, 2878, 2856, 1336; MS [EI+] m/z (%): 418 [M]+ (5),
125 [C7H6Cl]
+ (100). HRMS (EI): calcd. For C19H19ClN4O5:
418.1044; found: 418.1048.
2.2.8. 1-(2-Chlorobenzyloxy)-3-[4-(4-chlorophenoxymethyl)-[1,
2,3]triazol-1-yl]-propan-2-ol (14). White solid; yield: 89%;
mp 67-68∘C; 1H NMR (300MHz, CDCl3) 𝛿 7.73 (s, 1H),
7.41 (dd, J = 9.6, 4.8Hz, 1H), 7.30–7.20 (m, 5H), 6.94–6.89
(m, 2H), 5.16 (s, 2H), 4.63 (s, 2H), 4.60–4.40 (m, 2H), 4.29
(dd, J = 4.5, 3.7Hz, 1H), 3.62–3.46 (m, 2H), 2.95 (s, broad,
1H); 13C NMR (75MHz, CDCl3) 𝛿 156.1, 143.0, 134.3, 132.8,
128.9, 128.9, 128.8, 128.7, 128.7, 126.2, 123.6, 115.4, 70.5, 70.1,
68.5, 61.5, 52.2; IR (ATR, cm−1): 3168, 2921, 2869, 1489, 1237;
MS [EI+] m/z (%): 407 [M]+ (2), 185 [C9H10ClO]+ (80), 127
[C6H4ClO]
+ (100). HRMS (EI): calcd. For C19H19Cl2N3O3:
407.0803; found: 407.0808.
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Scheme 3: Reaction of azido alcohol 6 with phenylacetylene.
2.2.9. 1-(2-Chlorobenzyloxy)-3-[4-(6-methoxynaphthalen-2-
yl)-[1,2,3]triazol-1-yl]-propan-2-ol (15). White solid; yield:
94%; mp 100∘C; 1H NMR (300MHz, CDCl3) 𝛿 8.10 (s,
1H), 7.90 (s, 1H), 7.79 (dt, J = 8.5, 1.8Hz, 1H), 7.72 (s, 1H),
7.68 (dd, J = 8.8, 1.8Hz, 1H), 7.40 (dd, J = 17.1, 9.3Hz),
7.29–7.20 (m, 3H), 7.16–7.09 (m, 2H), 4.66 (s, 2H), 4.60–4.46
(ddd, J = 3.5, 13.9, 6.7Hz, 2H), 4.36 (s, 1H), 3.92 (s, 3H),
3.65–3.57 (dddd, J = 9.7, 4.9, 9.7, 5.5Hz, 2H), 2.16 (s, broad,
1H); 13C NMR (75MHz, CDCl3) 𝛿 157.9, 147.6, 135.1, 134.3,
133.4, 129.7, 129.6, 129.5, 129.2, 128.8, 127.3, 126.9, 125.5, 124.9,
121.2, 119.2, 105.7, 71.5, 70.8, 69.2, 55.3, 53.3; IR (ATR, cm−1):
3391, 3131, 2921, 2852, 1606, 1216; MS [EI+] m/z (%): 423
[M]+ (10), 226 [C13H10N3O]
+ (80), 185 [C9H10ClO]
+ (35),
125 [C7H6Cl]
+ (100). HRMS (EI): calcd. For C23H22ClN3O3:
423.1350; found: 423.1356.
2.2.10. 1-(2-Chlorobenzyloxy)-3-[4-(4-fluorophenyl)-[1,2,3]tri-
azol-1-yl]-propan-2-ol (16). Colorless oil; yield: 66%; 1H
NMR (300MHz, CDCl3) 𝛿 7.82 (s, 1H), 7.77–7.70 (m, 2H), 7.53
(dd, J = 5.7, 3.3Hz, 1H), 7.38 (td, J = 7.4, 2.2Hz, 1H), 7.26 (ddt,
J = 7.6, 2.2, 1.1 Hz, 1H), 7.30–7.21 (m, 2H), 7.09 (t, 𝐽 = 7.4Hz,
1H), 4.65 (d, 𝐽 = 0.8Hz, 2H), 4.61–4.46 (dd, J = 14.0, 7.0Hz,
2H), 4.31 (p, 𝐽 = 5.2Hz, 1H), 3.64–3.54 (dd, J = 9.7, 5.7Hz,
2H), 2.17 (s, 1H); 13C NMR (75MHz, CDCl3) 𝛿 164.1, 160.8,
146.5, 134.8, 133.2, 129.5, 129.4, 129.1, 127.2, 127.1, 126.7, 126.4,
120.8, 115.7, 115.5, 71.2, 70.6, 69.0, 52.9; IR (ATR, cm−1): 3365,
2922, 2864, 1497, 1224; MS [EI+] m/z (%): 361 [M]+ (25), 164
[C8H7FN3]
+ (100). HRMS (EI): calcd. For C18H17ClFN3O2:
361.0993; found: 361.0997.
2.2.11. 1-(2-Chlorobenzyloxy)-3-[4-(2,4-difluorophenyl)-[1,2,3]
triazol-1-yl]-propan-2-ol (17). White solid; yield: 67%; mp
77∘C; 1H NMR (300MHz, CDCl3) 𝛿 8.31–8.15 (m, 1H),
8.00 (s, 1H), 7.47–7.33 (m, 2H), 7.26 (dd, J = 5.9, 3.5Hz,
2H), 6.99 (td, J = 8.4, 2.6Hz, 1H), 6.88 (ddd, J = 11.1, 8.9,
2.6Hz, 1H), 4.66 (s, 2H), 4.61–4.49 (ddd, J = 14.1, 6.9, 3.7Hz,
2H), 4.37–4.27 (m, 1H), 3.65–3.55 (dddd, J = 9.7, 9.6, 5.6,
4.6Hz, 2H), 1.65 (s, broad, 1H); 13C NMR (75MHz, CDCl3)
𝛿 163.4, 160.1, 139.6, 134.9, 134.3, 132.6, 128.8, 128.5, 126.1,
123.21, 114.2, 111.1, 103.6, 70.74, 70.1, 68.5, 52.4; IR (ATR,
cm−1): 3194, 3151, 2908, 1361; MS [EI+] m/z (%): 379 [M]+
(10), 239 [C10H11F2N3O]
+ (100). HRMS (EI): calcd. For
C18H16ClF2N3O2: 379.0889; found: 379.0891.
2.2.12. 1-(2-Chlorobenzyloxy)-3-[4-(2-trifluoromethylphenyl)-
[1,2,3]triazol-1-yl]-propan-2-ol (18). Colorless oil; yield: 68%;
1HNMR (300MHz, CDCl3) 𝛿 7.91 (s, 1H), 7.90 (d, J = 6.9Hz,
1H), 7.73 (dd, J = 8.0, 1.4Hz, 1H), 7.47 (dd, J = 7.9, 1.5Hz, 1H),
7.42 (ddd, J =6.9, 3.7, 1.6Hz, 1H), 7.37–7.32 (m, 1H), 7.23 (td, J =
6.5, 5.7, 3.7Hz, 2H), 4.63 (d, J = 1.2Hz, 2H), 4.63–4.50 (dddd,
J = 14.1, 14.0, 6.8, 3.9Hz, 2H), 4.30 (dq, J = 9.8, 5.3Hz, 1H),
3.60–3.51 (dddd, J = 9.8, 9.7, 5.6, 4.9Hz, 2H), 1.26 (s, broad,
1H); 13C NMR (75MHz, CDCl3) 𝛿 163.4, 160.1, 139.6, 134.9,
134.3, 132.6, 128.8, 128.5, 126.1, 123.21, 114.2, 111.1, 103.6, 70.74,
70.1, 68.5, 52.4; IR (ATR, cm−1): 3344, 1354, 1168.86, 1107; MS
[EI+]m/z (%): 411 [M]+ (5), 125 [C7H6Cl]+ (100). HRMS (EI):
calcd. For C19H17ClF3N3O2: 411.0961; found: 411.0965.
2.3. Theoretical Calculations. All the electronic structure
computations were carried out with NWChem package [14].
A frequency analysis was applied to the optimized geometries
to verify the corresponding stability criterion. The PBEPBE
[15] exchange and correlation functional was used with the 6-
311++g∗∗ Pople’s basis set. All the reactivity parameters were
computed from a finite differences approach.
3. Results and Discussion
3.1. Chemistry. The first experiments were carried out
with the objective to prepare 1-azido-3-(2-chloro-benzyl-ox-
y)-propan-2-ol, 6 (Scheme 2). Initially, 2-chlorophenyl meth-
anol 4 prepared from reduction of 4-chlorobenzaldehyde 3
was reacted with epichlorohydrin to give the aryl epoxide 5
[9, 15] which was opened with sodium azide to afford azido
alcohol 6 in a 62% global yield from 4-chlorobenzaldehyde 3.
Azido alcohol6was the startingmaterial for the following
CuAAC experiments. In a model reaction, compound 6 was
treated with phenylacetylene in presence of diverse Cu(I)
catalytic sources according to that described by Rostovtsev et
al. [16], Tornøe et al. [17] and our group [18, 19] (Scheme 3),
obtaining compound 7 as only reaction product. From these
experiments presented in Table 1, we selected CuI-DIPEA
for CuAAC reaction because a best yield (85%) was reached
using this catalytic system.
Taking these optimized conditions, a synthetic procedure
was developed and a series of (2-chlorobenzyloxy)-1,2,3-
triazolyl-propan-2-ol derivatives was prepared from azido
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Table 1: Effect of catalyst, reducing agent, base, and solvent.
Entry Copper salt Reducing agent Base Solvent % yield
7 CuSO4 Glucose NaOH MeOH-H2O 34
8 CuSO4 Sodium ascorbate none tBuOH-H2O 28
9 CuI None NaOH MeOH-H2O 40
10 CuI None DIPEA MeOH 35
11 CuI None DIPEA CH2Cl2 85
R
Cl
O
OH
Cl
O
OH
N N
N
R
6
N3
CuI/CH2Cl2
Scheme 4
Table 2: 1,2,3-Triazoles prepared via CuAAC.
Compound R1 % yield
7 Ph 85
8 CH2O(4-CH3)C6H4 99
9 CH2O(4-OCH3)C6H4 46
10 4-CH3C6H4 51
11
O
O
CH2
66
12 (CH2)3OH 84
13 CH2O(4-NO2)C6H4 55
14 CH2O(4-Cl)C6H4 89
15
OCH3
94
16 4-FC6H4 66
17 2,4-FC6H3 67
18 2-CF3C6H4 68
alcohol 6 with different alkynes. The results in Table 2 show
that this process occurs with high efficiency and functional
group tolerance; see Scheme 4.
3.2. DFT Characterization. In order to compare triazoles
7–18 with compound 1 and to establish possible SSRI candi-
dates, a theoretical studywas carried out.The global reactivity
indexes of studied compounds are presented in Table 3,
electronic affinity (𝐴), ionization potential (𝐼), chemical
potential (𝜇), chemical softness (S), and electrophilicity (𝜔).
The obtained results are gathered in Table 3.
Ionization potential (𝐼) is defined as the energy needed to
remove an electron from a molecule. According to obtained
results, the molecule 12 showed the highest ionization poten-
tial value, and the molecule 15 has the closest value to 1,
showing that electron-rich aromatic rings are necessary to
mimic the properties of molecule 1. On the other hand,
the presence of electron attracting groups in the aromatics
increases the value of 𝐼; the aliphatic moieties have the same
effect.
Electron affinity (EA) measures the ability of a molecule
to accept electrons and form anions. There are some EA neg-
ative in the obtained values, because the molecules released
energy in the process of electron acceptance. In a general
view, only the half of the molecules has positive EA values
like one. Nevertheless, the computed values are different
compared with 1, with the molecules 16 with a behavior
closest to 1.
Chemical potential (𝜇)measures the escaping tendency of
an electronic cloud in the ground state system. The obtained
results shown that molecule 1 has higher value (less negative)
than synthesized triazolyl derivatives, making compound 1 a
better electron donor than obtained compounds. Neverthe-
less, almost all the compounds have pretty close values to 1,
except for compound 7 and in minor degree 12.
Chemical softness (S) is related to polarizability. The
values S for compounds 14 and 18 are remarkably close to the
value of compound 1, suggesting a similar facility to charge
transfer; other compounds with similar values are 15–17,
respectively. As matter of fact, the trifluorobenzyl group in
compound 18 shows similar characteristics to indolyl moiety
in compound 1.
Electrophilicity (𝜔) gives an idea of the stabilization
energy when the system acquires electrons from the envi-
ronment up to saturation. Since the electrophilicity power is
computed through (𝜇2/2𝜂), the differences in electrophilic-
ity power (𝜔) between the compounds are mainly due to
differences in their chemical potential. In this regard, the
results suggest that triazole moiety is a better nucleophile
for compounds 7–18 than tetrahydropyridine system in
compound 1. In a general way all the parameters obtained by
DFT calculations show the necessity of having an electron-
rich aromatic bond tomimic the indolylmoiety in compound
1.
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Table 3: Global reactivity indexes in eV.
A I 𝜇 𝑆 𝜔
1 0.113 6.546 −3.216 0.155 0.804
7 −1.042 7.717 −8.879 0.056 2.219
8 −0.162 7.593 −3.878 0.128 0.969
9 −0.129 7.250 −3.689 0.135 0.922
10 −0.105 7.510 −3.808 0.131 0.952
12 −0.158 8.362 −4.260 0.117 1.065
13 0.911 8.253 −3.671 0.136 0.917
14 0.347 7.312 −3.482 0.143 0.870
15 0.526 6.619 −3.044 0.164 0.761
16 0.271 7.397 −3.562 0.140 0.890
17 0.371 7.537 −3.583 0.139 0.895
18 0.568 7.688 −3.559 0.140 0.889
𝜇 = 1/2(𝜀𝐼 + 𝜀𝐴); 𝜂 = 𝜀𝐴 − 𝜀𝐼; 𝑆 = 1/; 𝜔 = 𝜇
2/2𝜂.
Table 4: Local reactivity indexes for selected atoms.
Compound 𝑓+ 𝑓− 𝑠+ 𝑠−
7
N1 0.01 0.04 0.01 0.06
N2 0.02 0.08 0.03 0.12
N3 0.02 0.04 0.03 0.06
8
N1 0.00 0.02 0.00 0.07
N2 0.01 0.03 0.03 0.10
N3 0.02 0.01 0.07 0.03
9
N1 0.00 0.04 0.00 0.14
N2 0.02 0.08 0.07 0.29
N3 0.01 0.04 0.03 0.14
10
N1 0.01 0.04 0.03 0.14
N2 0.02 0.08 0.07 0.28
N3 0.02 0.03 0.07 0.10
12
N1 0.00 0.03 0.00 0.11
N2 0.01 0.10 0.03 0.37
N3 0.01 0.04 0.03 0.14
13
N1 0.01 0.03 0.04 0.12
N2 0.02 0.06 0.08 0.23
N3 0.00 0.03 0.00 0.12
14
N1 0.02 0.01 0.08 0.13
N2 0.05 0.03 0.22 0.27
N3 0.03 0.02 0.13 0.13
15
N1 0.01 0.03 0.04 0.11
N2 0.03 0.05 0.11 0.19
N3 0.02 0.03 0.07 0.11
16
N1 0.02 0.02 0.07 0.07
N2 0.02 0.03 0.07 0.11
N3 0.03 0.04 0.11 0.15
17
N1 0.00 0.04 0.00 0.15
N2 0.02 0.07 0.07 0.27
N3 0.02 0.04 0.07 0.17
18
N1 0.02 0.02 0.08 0.08
N2 0.02 0.04 0.08 0.16
N3 0.03 0.03 0.12 0.12
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Figure 1: Dual descriptor 𝑓± for the molecules studied in this work.
The local properties of synthesized compounds are hard
to analyze due to the diverse nature of substituent groups
used in this study. For this reason, the three nitrogen atoms
in triazole ring were used as a probe for the local properties
in the prepared molecules. As shown in Table 4, the highest
values of 𝑓− can be observed for N2 atom in all molecules,
indicating that this atom is the most susceptible to a nucle-
ophilic attack. In addition, a visible tendency for the case of
𝑓+ was not found. The local softness (s) followed the same
tendencies as Fukui functions; nevertheless, this function
could be comparable between molecules, being higher in
compounds 14–18 on N2 atom.
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Other important index is known as dual descriptor 𝑓±
which contains information about the chemical philicity
(electrophilicity/nucleophilicity). In this case, the graphic
maps are generally sufficient for rationalizing the chemical
reactivity.Themaps of dual descriptor for the set ofmolecules
studied in this work are represented in Figure 1, displaying the
most probable sites for a possible nucleophilic-electrophilic
attack. In a general way, the most electrophilic sites are found
on the chlorobenzyl moiety, while the most nucleophilic sites
are located on the opposite side of the molecule independent
of the electronic nature of substituent group. These elements
reveal some similarities between compound 1 and synthe-
sized compounds with nearest values for compounds 14–18.
The calculated parameters also allow establishing interaction
sites in these molecules.
4. Conclusions
A new class of derivatives of chlorobenzyloxy triazolyl-
propan-2-ol was obtained from CuAAC reaction using
commercially available raw materials through simple and
efficient methods. Theoretical calculations indicate that a
high similarity can be found between these products and the
leading molecule 1; consequently, a good SSRI ability would
be expected for these compounds, suggesting more studies
about this topic. Also,DFTdescriptors show that the presence
of an electron-rich aromatic ring is necessary to mimic the
indolyl moiety present in compound 1.
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